semefab holdings limited

Live EstablishedMidDeclining

semefab holdings limited Company Information

Share SEMEFAB HOLDINGS LIMITED

Company Number

06649310

Directors

Keith Persin

Shareholders

stephen sverdloff

the sverdloff 2009 trust

View All

Group Structure

View All

Industry

Activities of head offices

 

Registered Address

6 dominus way, meridian business park, leicester, LE19 1RP

semefab holdings limited Estimated Valuation

£4.2m

Pomanda estimates the enterprise value of SEMEFAB HOLDINGS LIMITED at £4.2m based on a Turnover of £9.3m and 0.45x industry multiple (adjusted for size and gross margin).

semefab holdings limited Estimated Valuation

£0

Pomanda estimates the enterprise value of SEMEFAB HOLDINGS LIMITED at £0 based on an EBITDA of £-1.9m and a 3.55x industry multiple (adjusted for size and gross margin).

semefab holdings limited Estimated Valuation

£10.1m

Pomanda estimates the enterprise value of SEMEFAB HOLDINGS LIMITED at £10.1m based on Net Assets of £4.8m and 2.11x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Semefab Holdings Limited Overview

Semefab Holdings Limited is a live company located in leicester, LE19 1RP with a Companies House number of 06649310. It operates in the activities of head offices sector, SIC Code 70100. Founded in July 2008, it's largest shareholder is stephen sverdloff with a 76.6% stake. Semefab Holdings Limited is a established, mid sized company, Pomanda has estimated its turnover at £9.3m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Semefab Holdings Limited Health Check

Pomanda's financial health check has awarded Semefab Holdings Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 7 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

3 Strong

positive_score

2 Regular

positive_score

7 Weak

size

Size

annual sales of £9.3m, make it smaller than the average company (£20.2m)

£9.3m - Semefab Holdings Limited

£20.2m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -7%, show it is growing at a slower rate (7.4%)

-7% - Semefab Holdings Limited

7.4% - Industry AVG

production

Production

with a gross margin of 15.7%, this company has a higher cost of product (33.7%)

15.7% - Semefab Holdings Limited

33.7% - Industry AVG

profitability

Profitability

an operating margin of -30.5% make it less profitable than the average company (5.9%)

-30.5% - Semefab Holdings Limited

5.9% - Industry AVG

employees

Employees

with 110 employees, this is similar to the industry average (110)

110 - Semefab Holdings Limited

110 - Industry AVG

paystructure

Pay Structure

on an average salary of £46.1k, the company has an equivalent pay structure (£49.8k)

£46.1k - Semefab Holdings Limited

£49.8k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £84.8k, this is less efficient (£205.1k)

£84.8k - Semefab Holdings Limited

£205.1k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 23 days, this is earlier than average (45 days)

23 days - Semefab Holdings Limited

45 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 32 days, this is quicker than average (42 days)

32 days - Semefab Holdings Limited

42 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 64 days, this is more than average (48 days)

64 days - Semefab Holdings Limited

48 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 122 weeks, this is more cash available to meet short term requirements (15 weeks)

122 weeks - Semefab Holdings Limited

15 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 36.9%, this is a lower level of debt than the average (55.6%)

36.9% - Semefab Holdings Limited

55.6% - Industry AVG

SEMEFAB HOLDINGS LIMITED financials

EXPORTms excel logo

Semefab Holdings Limited's latest turnover from December 2023 is £9.3 million and the company has net assets of £4.8 million. According to their latest financial statements, Semefab Holdings Limited has 110 employees and maintains cash reserves of £2.9 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Turnover9,331,69315,513,83815,513,83813,416,74711,684,8889,930,36412,162,59011,199,1249,430,77610,384,7159,056,8147,949,3787,347,3498,650,0447,834,8246,444,416
Other Income Or Grants
Cost Of Sales7,865,2518,883,8978,883,8978,012,8517,207,1646,314,3778,022,1326,615,8456,073,3976,729,8906,423,3694,979,6994,982,5495,089,5044,586,4063,703,702
Gross Profit1,466,4426,629,9416,629,9415,403,8964,477,7243,615,9874,140,4584,583,2793,357,3793,654,8252,633,4452,969,6792,364,8003,560,5403,248,4182,740,714
Admin Expenses4,313,3524,344,7524,344,7523,881,6523,192,1793,498,1923,650,2193,627,8482,889,0473,447,2323,225,8012,856,5492,853,9572,876,4672,945,0471,912,817
Operating Profit-2,846,9102,285,1892,285,1891,522,2441,285,545117,795490,239955,431468,332207,593-592,356113,130-489,157684,073303,371827,897
Interest Payable120,64688,39988,39983,23287,29384,04172,63585,82895,73598,583104,382105,244107,085113,16288,80926,910
Interest Receivable41,3418,4168,4168,07012,6833,6962,6511,2694792137924527,32318,468
Pre-Tax Profit-2,996,4392,205,2062,205,2061,447,0821,210,93537,450420,255870,872373,076109,010-696,7177,923-596,150571,363219,096819,455
Tax454,155-310,407-310,407-536,442-217,01548,237450,856-26,431129,305217,000105,049-108,8742,150-37,796-98,311
Profit After Tax-2,542,2841,894,7991,894,799910,640993,92085,687871,111844,441502,381109,010-479,717112,972-705,024573,513181,300721,144
Dividends Paid128,368
Retained Profit-1,727,8491,145,8121,145,812572,808722,35420,988487,104379,513236,122-11,065-333,34520,126-323,212471,04890,975621,550
Employee Costs5,067,3525,062,8565,062,8564,759,5634,101,2723,791,1754,183,1673,644,2273,344,7033,301,9573,286,8772,545,8722,969,0002,978,9812,624,1512,612,067
Number Of Employees110131131123112112118100101101978191969090
EBITDA*-1,850,2343,077,2643,077,2652,285,6392,016,0491,413,3771,666,9892,575,3592,058,5971,215,362378,970772,550358,8742,367,9331,248,6961,414,505

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Tangible Assets6,146,2497,280,5127,280,5127,540,0048,473,0788,986,3499,787,1449,473,3539,327,32610,052,32110,833,30411,463,79811,865,50912,382,66812,782,4519,941,895
Intangible Assets-380,835-761,672-1,142,509
Investments & Other208,990
Debtors (Due After 1 year)200,000350,000350,000350,000350,000243,372243,372243,372243,372243,372243,372198,372329,758
Total Fixed Assets6,346,2497,630,5127,630,5127,890,0048,823,0788,986,3499,787,1449,473,3539,570,69810,295,69311,076,67611,707,17012,108,88112,245,20512,219,1519,338,134
Stock & work in progress1,394,4081,510,6011,510,6011,771,1212,008,9641,932,0451,195,6141,012,0381,030,0071,206,2851,086,4221,235,9921,281,7821,425,5491,059,0261,019,151
Trade Debtors599,6842,845,2272,845,2271,712,9021,363,2761,285,0761,362,3381,492,5701,190,6031,648,1791,397,2111,244,591980,4391,369,3751,397,945942,402
Group Debtors
Misc Debtors777,631218,155218,155258,950194,5181,461,015493,774529,118290,184355,554327,845395,803276,702384,014509,870633,505
Cash2,860,9894,962,9924,962,9924,284,1772,831,6491,694,4132,658,9023,001,8902,106,312580,450365,426442,515189,681760,2271,586,3421,193,845
misc current assets
total current assets5,632,7129,536,9759,536,9758,027,1506,398,4076,372,5495,710,6286,035,6164,617,1063,790,4683,176,9043,318,9012,728,6043,939,1654,553,1833,788,903
total assets11,978,96117,167,48717,167,48715,917,15415,221,48515,358,89815,497,77215,508,96914,187,80414,086,16114,253,58015,026,07114,837,48516,184,37016,772,33413,127,037
Bank overdraft78,561
Bank loan66,64788,51886,7642,096,94883,38081,91480,06278,538
Trade Creditors 690,6101,302,9501,302,950906,674983,9581,019,5771,475,8921,278,975986,8841,124,0671,033,563878,073764,0801,196,3641,225,2991,154,276
Group/Directors Accounts
other short term finances
hp & lease commitments58,251247,262247,262303,470314,711314,71167,44967,44912,95923,79611,81922,250
other current liabilities468,6481,690,1441,690,1442,057,7681,902,1181,733,2721,824,3271,834,4091,487,5971,245,753984,251779,793465,045495,838971,030958,507
total current liabilities1,217,5093,240,3563,240,3563,267,9123,200,7873,067,5603,367,6683,180,8332,541,1282,458,3382,183,1393,754,8141,325,4641,797,9122,288,2102,213,571
loans1,600,0001,600,0001,600,0001,600,0001,675,0001,775,0001,875,0001,975,0001,999,9252,066,5982,155,131229,9782,326,9242,410,1592,492,801572,285
hp & lease commitments99,46199,461346,723650,193964,904191,106258,55512,9593,47615,295
Accruals and Deferred Income1,243,5291,622,8553,639,1884,737,5364,943,3265,136,545
other liabilities110,031
provisions1,605,9052,001,4712,001,4712,324,452984,549751,5722,972,6783,874,3724,270,9831,048,650338,000433,000484,000364,000364,000308,000
total long term liabilities3,205,9053,700,9323,700,9324,271,1754,553,2715,114,3315,038,7846,107,9276,270,9086,754,4362,493,1315,400,5147,754,2507,923,6632,860,2771,005,611
total liabilities4,423,4146,941,2886,941,2887,539,0877,754,0588,181,8918,406,4529,288,7608,812,0369,212,7744,676,2709,155,3289,079,7149,721,5755,148,4873,219,182
net assets4,799,5706,476,0726,476,0725,723,7795,150,9714,506,3044,485,3163,998,2123,618,6993,382,5777,955,9154,102,9764,082,8504,406,0629,669,5798,043,912
total shareholders funds4,799,5706,476,0726,476,0725,723,7795,150,9714,506,3044,485,3163,998,2123,618,6993,382,5777,955,9154,102,9764,082,8504,406,0629,669,5798,043,912
Dec 2023Dec 2022Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Operating Activities
Operating Profit-2,846,9102,285,1892,285,1891,522,2441,285,545117,795490,239955,431468,332207,593-592,356113,130-489,157684,073303,371827,897
Depreciation1,376,5061,170,4561,170,4561,142,7211,109,8301,295,5821,176,7501,067,1321,038,9911,007,769971,326457,898467,1961,303,4731,326,162205,771
Amortisation-379,830-378,381-378,380-379,326-379,326552,796551,274201,522380,835380,387-380,837380,837
Tax454,155-310,407-310,407-536,442-217,01548,237450,856-26,431129,305217,000105,049-108,8742,150-37,796-98,311
Stock-116,193-260,520-260,520-237,84376,919736,431183,576-17,969-176,278119,863-149,570-45,790-143,767366,52339,8751,019,151
Debtors-1,836,0671,091,5301,091,530414,058-838,297889,979-165,576297,529-522,946278,67784,662383,253-496,248-109,426200,5221,905,665
Creditors-612,340396,276396,276-77,284-35,619-456,315196,917292,091-137,18390,504155,490113,993-432,284-28,93571,0231,154,276
Accruals and Deferred Income-1,221,496-367,624-367,624-1,087,879-210,4801,531,800-10,082346,812-3,397,3443,900,690-4,533,078108,958-224,0124,661,35312,523958,507
Deferred Taxes & Provisions-395,566-322,981-322,9811,339,903232,977-2,221,106-901,694-396,6113,222,333710,650-95,000-51,000120,00056,000308,000
Cash flow from operations-1,673,2211,641,5181,641,5191,747,7222,547,290-1,310,4171,384,9862,511,6602,574,9325,518,666-3,811,710712,087353,7196,745,4041,110,049812,161
Investing Activities
capital expenditure-1,400,541-745,914-313,996-373,367-340,832-62,764-81,106-1,315,514-2,071,934-1,598,418
Change in Investments-208,990208,990
cash flow from investments-1,400,541-745,914-313,996-373,367-340,832-62,764-81,106-1,315,514-1,862,944-1,807,408
Financing Activities
Bank loans-66,647-21,8711,754-2,010,1842,013,5681,4661,8521,52478,538
Group/Directors Accounts
Other Short Term Loans
Long term loans-75,000-100,000-100,000-100,000-24,925-66,673-88,5331,925,153-2,096,946-83,235-82,6421,920,516572,285
Hire Purchase and Lease Commitments-288,472-303,470-303,470-314,711-314,7111,021,060-67,449326,004-12,959-23,79621,460-22,25037,545
other long term liabilities-110,031110,031
share issue51,347-393,519-393,519-77,687-4,562,2734,186,284-5,734,5651,534,6927,422,362
interest-79,305-79,983-79,983-75,162-74,610-80,345-69,984-84,559-95,256-98,583-104,361-105,207-106,993-112,710-81,486-8,442
cash flow from financing-316,430-776,972-776,972-464,873-567,008840,715-237,433149,873-183,800-4,747,6353,996,892-201,544-212,558-5,906,6053,242,9658,212,319
cash and cash equivalents
cash-2,102,003678,815678,8151,452,5281,137,236-964,489-342,988895,5781,525,862215,024-77,089252,834-570,546-826,115392,4971,193,845
overdraft-78,56178,561
change in cash-2,102,003678,815678,8151,452,5281,137,236-964,489-342,988895,5781,525,862293,585-155,650252,834-570,546-826,115392,4971,193,845

semefab holdings limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for semefab holdings limited. Get real-time insights into semefab holdings limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Semefab Holdings Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for semefab holdings limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in LE19 area or any other competitors across 12 key performance metrics.

semefab holdings limited Ownership

SEMEFAB HOLDINGS LIMITED group structure

Semefab Holdings Limited has 1 subsidiary company.

Ultimate parent company

SEMEFAB HOLDINGS LIMITED

06649310

1 subsidiary

SEMEFAB HOLDINGS LIMITED Shareholders

stephen sverdloff 76.56%
the sverdloff 2009 trust 14.84%
roger bacon 7.81%
josephine hicks 0.78%

semefab holdings limited directors

Semefab Holdings Limited currently has 1 director, Mr Keith Persin serving since Jul 2008.

officercountryagestartendrole
Mr Keith PersinUnited Kingdom61 years Jul 2008- Director

P&L

December 2023

turnover

9.3m

-40%

operating profit

-2.8m

-225%

gross margin

15.8%

-63.23%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

4.8m

-0.26%

total assets

12m

-0.3%

cash

2.9m

-0.42%

net assets

Total assets minus all liabilities

semefab holdings limited company details

company number

06649310

Type

Private limited with Share Capital

industry

70100 - Activities of head offices

incorporation date

July 2008

age

17

incorporated

UK

ultimate parent company

None

accounts

Group

last accounts submitted

December 2023

previous names

hicks (1) limited (September 2022)

accountant

-

auditor

FORVIS MAZARS LLP

address

6 dominus way, meridian business park, leicester, LE19 1RP

Bank

-

Legal Advisor

-

semefab holdings limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to semefab holdings limited.

semefab holdings limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for SEMEFAB HOLDINGS LIMITED. This can take several minutes, an email will notify you when this has completed.

semefab holdings limited Companies House Filings - See Documents

datedescriptionview/download